nodes	percent_of_prediction	percent_of_DWPC	metapath
Sunitinib—LATS2—malignant glioma	0.231	0.355	CbGaD
Sunitinib—MYLK—malignant glioma	0.149	0.229	CbGaD
Sunitinib—FGFR1—malignant glioma	0.0636	0.0979	CbGaD
Sunitinib—FLT1—malignant glioma	0.0608	0.0936	CbGaD
Sunitinib—NTRK1—malignant glioma	0.0591	0.091	CbGaD
Sunitinib—PDGFRA—malignant glioma	0.049	0.0754	CbGaD
Sunitinib—KDR—malignant glioma	0.0381	0.0587	CbGaD
Sunitinib—Cerebral infarction—Carmustine—malignant glioma	0.00153	0.0261	CcSEcCtD
Sunitinib—Pigmentation disorder—Temozolomide—malignant glioma	0.00144	0.0246	CcSEcCtD
Sunitinib—Impaired healing—Carmustine—malignant glioma	0.00115	0.0196	CcSEcCtD
Sunitinib—Myelosuppression—Carmustine—malignant glioma	0.00106	0.0181	CcSEcCtD
Sunitinib—Myelosuppression—Temozolomide—malignant glioma	0.00103	0.0175	CcSEcCtD
Sunitinib—Transient ischaemic attack—Temozolomide—malignant glioma	0.000953	0.0163	CcSEcCtD
Sunitinib—Lymphopenia—Temozolomide—malignant glioma	0.00094	0.016	CcSEcCtD
Sunitinib—Skin hyperpigmentation—Carmustine—malignant glioma	0.000837	0.0143	CcSEcCtD
Sunitinib—Febrile neutropenia—Carmustine—malignant glioma	0.000827	0.0141	CcSEcCtD
Sunitinib—Haemorrhoids—Temozolomide—malignant glioma	0.000818	0.014	CcSEcCtD
Sunitinib—Febrile neutropenia—Temozolomide—malignant glioma	0.000799	0.0136	CcSEcCtD
Sunitinib—Deep vein thrombosis—Temozolomide—malignant glioma	0.000791	0.0135	CcSEcCtD
Sunitinib—Oral candidiasis—Carmustine—malignant glioma	0.000783	0.0134	CcSEcCtD
Sunitinib—Oral candidiasis—Temozolomide—malignant glioma	0.000757	0.0129	CcSEcCtD
Sunitinib—Embolism—Temozolomide—malignant glioma	0.000749	0.0128	CcSEcCtD
Sunitinib—Thrombosis—Carmustine—malignant glioma	0.000703	0.012	CcSEcCtD
Sunitinib—Myopathy—Temozolomide—malignant glioma	0.000686	0.0117	CcSEcCtD
Sunitinib—Hepatotoxicity—Carmustine—malignant glioma	0.000645	0.011	CcSEcCtD
Sunitinib—Abscess—Carmustine—malignant glioma	0.000629	0.0107	CcSEcCtD
Sunitinib—Hepatotoxicity—Temozolomide—malignant glioma	0.000623	0.0106	CcSEcCtD
Sunitinib—Hyperaesthesia—Temozolomide—malignant glioma	0.000613	0.0105	CcSEcCtD
Sunitinib—Endocrine disorder—Temozolomide—malignant glioma	0.00058	0.0099	CcSEcCtD
Sunitinib—Viral infection—Temozolomide—malignant glioma	0.000532	0.00909	CcSEcCtD
Sunitinib—Pulmonary embolism—Carmustine—malignant glioma	0.000498	0.0085	CcSEcCtD
Sunitinib—Respiratory failure—Temozolomide—malignant glioma	0.00049	0.00836	CcSEcCtD
Sunitinib—Musculoskeletal pain—Temozolomide—malignant glioma	0.000487	0.00831	CcSEcCtD
Sunitinib—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.000481	0.00821	CcSEcCtD
Sunitinib—Pulmonary embolism—Temozolomide—malignant glioma	0.000481	0.00821	CcSEcCtD
Sunitinib—Depressed level of consciousness—Carmustine—malignant glioma	0.000481	0.0082	CcSEcCtD
Sunitinib—Candida infection—Carmustine—malignant glioma	0.000475	0.00811	CcSEcCtD
Sunitinib—Skin exfoliation—Carmustine—malignant glioma	0.000475	0.00811	CcSEcCtD
Sunitinib—Influenza like illness—Temozolomide—malignant glioma	0.000467	0.00797	CcSEcCtD
Sunitinib—Depressed level of consciousness—Temozolomide—malignant glioma	0.000464	0.00793	CcSEcCtD
Sunitinib—Candida infection—Temozolomide—malignant glioma	0.000459	0.00784	CcSEcCtD
Sunitinib—Skin exfoliation—Temozolomide—malignant glioma	0.000459	0.00784	CcSEcCtD
Sunitinib—Neoplasm—Carmustine—malignant glioma	0.00045	0.00768	CcSEcCtD
Sunitinib—Neoplasm—Temozolomide—malignant glioma	0.000435	0.00742	CcSEcCtD
Sunitinib—Sepsis—Carmustine—malignant glioma	0.000432	0.00737	CcSEcCtD
Sunitinib—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.000401	0.00685	CcSEcCtD
Sunitinib—Hepatic failure—Temozolomide—malignant glioma	0.000388	0.00663	CcSEcCtD
Sunitinib—Nasal congestion—Temozolomide—malignant glioma	0.000383	0.00654	CcSEcCtD
Sunitinib—Hot flush—Temozolomide—malignant glioma	0.000373	0.00637	CcSEcCtD
Sunitinib—Menopausal symptoms—Temozolomide—malignant glioma	0.00037	0.00632	CcSEcCtD
Sunitinib—Hyponatraemia—Carmustine—malignant glioma	0.000363	0.00619	CcSEcCtD
Sunitinib—Face oedema—Carmustine—malignant glioma	0.000349	0.00595	CcSEcCtD
Sunitinib—Face oedema—Temozolomide—malignant glioma	0.000337	0.00575	CcSEcCtD
Sunitinib—Liver function test abnormal—Carmustine—malignant glioma	0.000334	0.00569	CcSEcCtD
Sunitinib—Hypokalaemia—Carmustine—malignant glioma	0.000329	0.00561	CcSEcCtD
Sunitinib—Dehydration—Temozolomide—malignant glioma	0.000325	0.00554	CcSEcCtD
Sunitinib—Dry skin—Temozolomide—malignant glioma	0.00032	0.00546	CcSEcCtD
Sunitinib—Muscular weakness—Carmustine—malignant glioma	0.000319	0.00544	CcSEcCtD
Sunitinib—Hypokalaemia—Temozolomide—malignant glioma	0.000318	0.00542	CcSEcCtD
Sunitinib—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.000314	0.00537	CcSEcCtD
Sunitinib—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.000314	0.00537	CcSEcCtD
Sunitinib—Dysphagia—Carmustine—malignant glioma	0.000312	0.00533	CcSEcCtD
Sunitinib—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.000308	0.00526	CcSEcCtD
Sunitinib—Muscular weakness—Temozolomide—malignant glioma	0.000308	0.00526	CcSEcCtD
Sunitinib—Abdominal distension—Temozolomide—malignant glioma	0.000304	0.00519	CcSEcCtD
Sunitinib—Dysphagia—Temozolomide—malignant glioma	0.000302	0.00515	CcSEcCtD
Sunitinib—Pancytopenia—Carmustine—malignant glioma	0.000297	0.00506	CcSEcCtD
Sunitinib—Neutropenia—Carmustine—malignant glioma	0.000292	0.00498	CcSEcCtD
Sunitinib—Bronchitis—Temozolomide—malignant glioma	0.00029	0.00495	CcSEcCtD
Sunitinib—Pancytopenia—Temozolomide—malignant glioma	0.000287	0.00489	CcSEcCtD
Sunitinib—Neutropenia—Temozolomide—malignant glioma	0.000282	0.00482	CcSEcCtD
Sunitinib—Hyperglycaemia—Carmustine—malignant glioma	0.000282	0.00481	CcSEcCtD
Sunitinib—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00028	0.00479	CcSEcCtD
Sunitinib—Pneumonia—Carmustine—malignant glioma	0.00028	0.00478	CcSEcCtD
Sunitinib—Depression—Carmustine—malignant glioma	0.000278	0.00474	CcSEcCtD
Sunitinib—Renal failure—Carmustine—malignant glioma	0.000274	0.00467	CcSEcCtD
Sunitinib—Weight decreased—Temozolomide—malignant glioma	0.000273	0.00466	CcSEcCtD
Sunitinib—Neuropathy peripheral—Carmustine—malignant glioma	0.000273	0.00466	CcSEcCtD
Sunitinib—Hyperglycaemia—Temozolomide—malignant glioma	0.000272	0.00465	CcSEcCtD
Sunitinib—Stomatitis—Carmustine—malignant glioma	0.000271	0.00463	CcSEcCtD
Sunitinib—Urinary tract infection—Carmustine—malignant glioma	0.000271	0.00462	CcSEcCtD
Sunitinib—Pneumonia—Temozolomide—malignant glioma	0.000271	0.00462	CcSEcCtD
Sunitinib—Infestation—Temozolomide—malignant glioma	0.000269	0.00459	CcSEcCtD
Sunitinib—Infestation NOS—Temozolomide—malignant glioma	0.000269	0.00459	CcSEcCtD
Sunitinib—Depression—Temozolomide—malignant glioma	0.000268	0.00458	CcSEcCtD
Sunitinib—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.000267	0.00455	CcSEcCtD
Sunitinib—Neuropathy peripheral—Temozolomide—malignant glioma	0.000264	0.0045	CcSEcCtD
Sunitinib—Stomatitis—Temozolomide—malignant glioma	0.000262	0.00448	CcSEcCtD
Sunitinib—Urinary tract infection—Temozolomide—malignant glioma	0.000262	0.00446	CcSEcCtD
Sunitinib—Hepatobiliary disease—Temozolomide—malignant glioma	0.000254	0.00434	CcSEcCtD
Sunitinib—Haemoglobin—Carmustine—malignant glioma	0.000251	0.00429	CcSEcCtD
Sunitinib—Haemorrhage—Carmustine—malignant glioma	0.00025	0.00427	CcSEcCtD
Sunitinib—Hypoaesthesia—Carmustine—malignant glioma	0.000249	0.00424	CcSEcCtD
Sunitinib—Oedema peripheral—Carmustine—malignant glioma	0.000246	0.0042	CcSEcCtD
Sunitinib—Connective tissue disorder—Carmustine—malignant glioma	0.000246	0.00419	CcSEcCtD
Sunitinib—Haemoglobin—Temozolomide—malignant glioma	0.000243	0.00414	CcSEcCtD
Sunitinib—Hepatitis—Temozolomide—malignant glioma	0.000242	0.00412	CcSEcCtD
Sunitinib—Haemorrhage—Temozolomide—malignant glioma	0.000242	0.00412	CcSEcCtD
Sunitinib—Hypoaesthesia—Temozolomide—malignant glioma	0.00024	0.0041	CcSEcCtD
Sunitinib—Urinary tract disorder—Temozolomide—malignant glioma	0.000239	0.00407	CcSEcCtD
Sunitinib—Oedema peripheral—Temozolomide—malignant glioma	0.000238	0.00406	CcSEcCtD
Sunitinib—Connective tissue disorder—Temozolomide—malignant glioma	0.000237	0.00405	CcSEcCtD
Sunitinib—Urethral disorder—Temozolomide—malignant glioma	0.000237	0.00404	CcSEcCtD
Sunitinib—Eye disorder—Carmustine—malignant glioma	0.000234	0.00399	CcSEcCtD
Sunitinib—Flushing—Carmustine—malignant glioma	0.000232	0.00396	CcSEcCtD
Sunitinib—Erythema multiforme—Temozolomide—malignant glioma	0.000228	0.0039	CcSEcCtD
Sunitinib—Eye disorder—Temozolomide—malignant glioma	0.000226	0.00385	CcSEcCtD
Sunitinib—Flushing—Temozolomide—malignant glioma	0.000224	0.00383	CcSEcCtD
Sunitinib—Cardiac disorder—Temozolomide—malignant glioma	0.000224	0.00383	CcSEcCtD
Sunitinib—Arrhythmia—Carmustine—malignant glioma	0.000223	0.00381	CcSEcCtD
Sunitinib—Alopecia—Carmustine—malignant glioma	0.000221	0.00377	CcSEcCtD
Sunitinib—Angiopathy—Temozolomide—malignant glioma	0.000219	0.00374	CcSEcCtD
Sunitinib—Mental disorder—Carmustine—malignant glioma	0.000219	0.00374	CcSEcCtD
Sunitinib—Immune system disorder—Temozolomide—malignant glioma	0.000218	0.00372	CcSEcCtD
Sunitinib—Mediastinal disorder—Temozolomide—malignant glioma	0.000218	0.00372	CcSEcCtD
Sunitinib—Malnutrition—Carmustine—malignant glioma	0.000218	0.00371	CcSEcCtD
Sunitinib—Erythema—Carmustine—malignant glioma	0.000218	0.00371	CcSEcCtD
Sunitinib—Chills—Temozolomide—malignant glioma	0.000217	0.0037	CcSEcCtD
Sunitinib—Alopecia—Temozolomide—malignant glioma	0.000213	0.00364	CcSEcCtD
Sunitinib—Mental disorder—Temozolomide—malignant glioma	0.000212	0.00361	CcSEcCtD
Sunitinib—Back pain—Carmustine—malignant glioma	0.00021	0.00359	CcSEcCtD
Sunitinib—Erythema—Temozolomide—malignant glioma	0.00021	0.00359	CcSEcCtD
Sunitinib—Malnutrition—Temozolomide—malignant glioma	0.00021	0.00359	CcSEcCtD
Sunitinib—Dysgeusia—Temozolomide—malignant glioma	0.000206	0.00351	CcSEcCtD
Sunitinib—Back pain—Temozolomide—malignant glioma	0.000203	0.00347	CcSEcCtD
Sunitinib—Anaemia—Carmustine—malignant glioma	0.000201	0.00343	CcSEcCtD
Sunitinib—Leukopenia—Carmustine—malignant glioma	0.000195	0.00332	CcSEcCtD
Sunitinib—Anaemia—Temozolomide—malignant glioma	0.000194	0.00332	CcSEcCtD
Sunitinib—Angioedema—Temozolomide—malignant glioma	0.000192	0.00328	CcSEcCtD
Sunitinib—Convulsion—Carmustine—malignant glioma	0.000188	0.00322	CcSEcCtD
Sunitinib—Leukopenia—Temozolomide—malignant glioma	0.000188	0.00321	CcSEcCtD
Sunitinib—Hypertension—Carmustine—malignant glioma	0.000188	0.00321	CcSEcCtD
Sunitinib—Myalgia—Carmustine—malignant glioma	0.000185	0.00316	CcSEcCtD
Sunitinib—Chest pain—Carmustine—malignant glioma	0.000185	0.00316	CcSEcCtD
Sunitinib—Cough—Temozolomide—malignant glioma	0.000183	0.00313	CcSEcCtD
Sunitinib—Convulsion—Temozolomide—malignant glioma	0.000182	0.00311	CcSEcCtD
Sunitinib—Hypertension—Temozolomide—malignant glioma	0.000182	0.0031	CcSEcCtD
Sunitinib—Myalgia—Temozolomide—malignant glioma	0.000179	0.00306	CcSEcCtD
Sunitinib—Arthralgia—Temozolomide—malignant glioma	0.000179	0.00306	CcSEcCtD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000178	0.00303	CcSEcCtD
Sunitinib—Oedema—Carmustine—malignant glioma	0.000178	0.00303	CcSEcCtD
Sunitinib—Infection—Carmustine—malignant glioma	0.000176	0.00301	CcSEcCtD
Sunitinib—Dry mouth—Temozolomide—malignant glioma	0.000175	0.00299	CcSEcCtD
Sunitinib—Thrombocytopenia—Carmustine—malignant glioma	0.000174	0.00297	CcSEcCtD
Sunitinib—Oedema—Temozolomide—malignant glioma	0.000172	0.00293	CcSEcCtD
Sunitinib—Infection—Temozolomide—malignant glioma	0.00017	0.00291	CcSEcCtD
Sunitinib—Anorexia—Carmustine—malignant glioma	0.000169	0.00289	CcSEcCtD
Sunitinib—Nervous system disorder—Temozolomide—malignant glioma	0.000168	0.00287	CcSEcCtD
Sunitinib—Thrombocytopenia—Temozolomide—malignant glioma	0.000168	0.00287	CcSEcCtD
Sunitinib—Skin disorder—Temozolomide—malignant glioma	0.000167	0.00285	CcSEcCtD
Sunitinib—Anorexia—Temozolomide—malignant glioma	0.000164	0.00279	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000162	0.00276	CcSEcCtD
Sunitinib—Insomnia—Carmustine—malignant glioma	0.000161	0.00274	CcSEcCtD
Sunitinib—Paraesthesia—Carmustine—malignant glioma	0.000159	0.00272	CcSEcCtD
Sunitinib—Dyspnoea—Carmustine—malignant glioma	0.000158	0.0027	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000156	0.00267	CcSEcCtD
Sunitinib—Insomnia—Temozolomide—malignant glioma	0.000155	0.00265	CcSEcCtD
Sunitinib—Decreased appetite—Carmustine—malignant glioma	0.000154	0.00263	CcSEcCtD
Sunitinib—Paraesthesia—Temozolomide—malignant glioma	0.000154	0.00263	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Carmustine—malignant glioma	0.000153	0.00262	CcSEcCtD
Sunitinib—Dyspnoea—Temozolomide—malignant glioma	0.000153	0.00261	CcSEcCtD
Sunitinib—Constipation—Carmustine—malignant glioma	0.000152	0.00259	CcSEcCtD
Sunitinib—Pain—Carmustine—malignant glioma	0.000152	0.00259	CcSEcCtD
Sunitinib—Dyspepsia—Temozolomide—malignant glioma	0.000151	0.00258	CcSEcCtD
Sunitinib—Decreased appetite—Temozolomide—malignant glioma	0.000149	0.00255	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000148	0.00253	CcSEcCtD
Sunitinib—Fatigue—Temozolomide—malignant glioma	0.000148	0.00253	CcSEcCtD
Sunitinib—Pain—Temozolomide—malignant glioma	0.000147	0.0025	CcSEcCtD
Sunitinib—Constipation—Temozolomide—malignant glioma	0.000147	0.0025	CcSEcCtD
Sunitinib—Gastrointestinal pain—Carmustine—malignant glioma	0.000145	0.00248	CcSEcCtD
Sunitinib—Body temperature increased—Carmustine—malignant glioma	0.00014	0.0024	CcSEcCtD
Sunitinib—Abdominal pain—Carmustine—malignant glioma	0.00014	0.0024	CcSEcCtD
Sunitinib—Gastrointestinal pain—Temozolomide—malignant glioma	0.00014	0.0024	CcSEcCtD
Sunitinib—Abdominal pain—Temozolomide—malignant glioma	0.000136	0.00232	CcSEcCtD
Sunitinib—Body temperature increased—Temozolomide—malignant glioma	0.000136	0.00232	CcSEcCtD
Sunitinib—Hypersensitivity—Carmustine—malignant glioma	0.000131	0.00223	CcSEcCtD
Sunitinib—Asthenia—Carmustine—malignant glioma	0.000127	0.00217	CcSEcCtD
Sunitinib—Hypersensitivity—Temozolomide—malignant glioma	0.000126	0.00216	CcSEcCtD
Sunitinib—IRAK4—spinal cord—malignant glioma	0.000126	0.00115	CbGeAlD
Sunitinib—AURKC—brain—malignant glioma	0.000126	0.00115	CbGeAlD
Sunitinib—ROCK1—central nervous system—malignant glioma	0.000126	0.00115	CbGeAlD
Sunitinib—PKN1—brain—malignant glioma	0.000125	0.00114	CbGeAlD
Sunitinib—CSNK1G2—brain—malignant glioma	0.000125	0.00114	CbGeAlD
Sunitinib—STK3—cerebellum—malignant glioma	0.000125	0.00114	CbGeAlD
Sunitinib—MAP3K7—midbrain—malignant glioma	0.000124	0.00114	CbGeAlD
Sunitinib—MAP2K2—spinal cord—malignant glioma	0.000123	0.00113	CbGeAlD
Sunitinib—ULK3—spinal cord—malignant glioma	0.000123	0.00113	CbGeAlD
Sunitinib—SLK—medulla oblongata—malignant glioma	0.000123	0.00113	CbGeAlD
Sunitinib—PRPF4—brain—malignant glioma	0.000123	0.00113	CbGeAlD
Sunitinib—Asthenia—Temozolomide—malignant glioma	0.000123	0.0021	CcSEcCtD
Sunitinib—TBK1—midbrain—malignant glioma	0.000123	0.00112	CbGeAlD
Sunitinib—DYRK1A—central nervous system—malignant glioma	0.000123	0.00112	CbGeAlD
Sunitinib—TYK2—midbrain—malignant glioma	0.000122	0.00112	CbGeAlD
Sunitinib—MAP2K5—telencephalon—malignant glioma	0.000122	0.00111	CbGeAlD
Sunitinib—KIT—brainstem—malignant glioma	0.000122	0.00111	CbGeAlD
Sunitinib—JAK2—medulla oblongata—malignant glioma	0.000122	0.00111	CbGeAlD
Sunitinib—PRPF4B—brain—malignant glioma	0.000122	0.00111	CbGeAlD
Sunitinib—Diarrhoea—Carmustine—malignant glioma	0.000121	0.00207	CcSEcCtD
Sunitinib—Pruritus—Temozolomide—malignant glioma	0.000121	0.00207	CcSEcCtD
Sunitinib—MAP3K7—spinal cord—malignant glioma	0.000121	0.00111	CbGeAlD
Sunitinib—IRAK1—midbrain—malignant glioma	0.000121	0.0011	CbGeAlD
Sunitinib—DYRK1A—cerebellum—malignant glioma	0.00012	0.0011	CbGeAlD
Sunitinib—TBK1—spinal cord—malignant glioma	0.00012	0.0011	CbGeAlD
Sunitinib—MERTK—central nervous system—malignant glioma	0.00012	0.0011	CbGeAlD
Sunitinib—FYN—medulla oblongata—malignant glioma	0.00012	0.0011	CbGeAlD
Sunitinib—STK39—brain—malignant glioma	0.00012	0.0011	CbGeAlD
Sunitinib—TYK2—spinal cord—malignant glioma	0.000119	0.00109	CbGeAlD
Sunitinib—CSF1R—telencephalon—malignant glioma	0.000119	0.00109	CbGeAlD
Sunitinib—CSNK2A1—brain—malignant glioma	0.000118	0.00108	CbGeAlD
Sunitinib—RPS6KB1—midbrain—malignant glioma	0.000118	0.00108	CbGeAlD
Sunitinib—MAP4K4—central nervous system—malignant glioma	0.000118	0.00108	CbGeAlD
Sunitinib—RET—midbrain—malignant glioma	0.000118	0.00107	CbGeAlD
Sunitinib—Dizziness—Carmustine—malignant glioma	0.000117	0.002	CcSEcCtD
Sunitinib—Diarrhoea—Temozolomide—malignant glioma	0.000117	0.002	CcSEcCtD
Sunitinib—MERTK—cerebellum—malignant glioma	0.000117	0.00107	CbGeAlD
Sunitinib—MAP4K5—medulla oblongata—malignant glioma	0.000117	0.00107	CbGeAlD
Sunitinib—MAP3K3—medulla oblongata—malignant glioma	0.000117	0.00107	CbGeAlD
Sunitinib—AXL—midbrain—malignant glioma	0.000117	0.00107	CbGeAlD
Sunitinib—MYLK—brain—malignant glioma	0.000117	0.00107	CbGeAlD
Sunitinib—MAP3K12—central nervous system—malignant glioma	0.000116	0.00106	CbGeAlD
Sunitinib—RPS6KB1—spinal cord—malignant glioma	0.000115	0.00105	CbGeAlD
Sunitinib—PLK4—brain—malignant glioma	0.000115	0.00105	CbGeAlD
Sunitinib—MAP4K4—cerebellum—malignant glioma	0.000115	0.00105	CbGeAlD
Sunitinib—RET—spinal cord—malignant glioma	0.000115	0.00105	CbGeAlD
Sunitinib—STK4—brain—malignant glioma	0.000115	0.00105	CbGeAlD
Sunitinib—RPS6KA3—central nervous system—malignant glioma	0.000114	0.00105	CbGeAlD
Sunitinib—AXL—spinal cord—malignant glioma	0.000114	0.00104	CbGeAlD
Sunitinib—NUAK2—cerebellum—malignant glioma	0.000114	0.00104	CbGeAlD
Sunitinib—Procainamide—BCHE—malignant glioma	0.000114	1	CrCbGaD
Sunitinib—MAP2K1—central nervous system—malignant glioma	0.000114	0.00104	CbGeAlD
Sunitinib—Dizziness—Temozolomide—malignant glioma	0.000113	0.00194	CcSEcCtD
Sunitinib—FLT3—cerebellum—malignant glioma	0.000113	0.00104	CbGeAlD
Sunitinib—MAP3K12—cerebellum—malignant glioma	0.000113	0.00104	CbGeAlD
Sunitinib—FLT1—medulla oblongata—malignant glioma	0.000113	0.00103	CbGeAlD
Sunitinib—Vomiting—Carmustine—malignant glioma	0.000113	0.00193	CcSEcCtD
Sunitinib—SLK—midbrain—malignant glioma	0.000113	0.00103	CbGeAlD
Sunitinib—PHKG2—brain—malignant glioma	0.000113	0.00103	CbGeAlD
Sunitinib—CSNK1A1—central nervous system—malignant glioma	0.000112	0.00103	CbGeAlD
Sunitinib—Rash—Carmustine—malignant glioma	0.000112	0.00191	CcSEcCtD
Sunitinib—EPHB6—medulla oblongata—malignant glioma	0.000112	0.00102	CbGeAlD
Sunitinib—STK24—brain—malignant glioma	0.000112	0.00102	CbGeAlD
Sunitinib—Dermatitis—Carmustine—malignant glioma	0.000112	0.00191	CcSEcCtD
Sunitinib—RPS6KA3—cerebellum—malignant glioma	0.000112	0.00102	CbGeAlD
Sunitinib—CLK1—central nervous system—malignant glioma	0.000111	0.00102	CbGeAlD
Sunitinib—Headache—Carmustine—malignant glioma	0.000111	0.0019	CcSEcCtD
Sunitinib—MAP2K1—cerebellum—malignant glioma	0.000111	0.00102	CbGeAlD
Sunitinib—DAPK2—brain—malignant glioma	0.000111	0.00101	CbGeAlD
Sunitinib—SLK—spinal cord—malignant glioma	0.00011	0.001	CbGeAlD
Sunitinib—CSNK1A1—cerebellum—malignant glioma	0.00011	0.001	CbGeAlD
Sunitinib—FYN—midbrain—malignant glioma	0.00011	0.001	CbGeAlD
Sunitinib—CAMK2G—central nervous system—malignant glioma	0.000109	0.001	CbGeAlD
Sunitinib—BMP2K—central nervous system—malignant glioma	0.000109	0.001	CbGeAlD
Sunitinib—Vomiting—Temozolomide—malignant glioma	0.000109	0.00186	CcSEcCtD
Sunitinib—FGFR2—spinal cord—malignant glioma	0.000109	0.000996	CbGeAlD
Sunitinib—CLK1—cerebellum—malignant glioma	0.000109	0.000995	CbGeAlD
Sunitinib—STK16—brain—malignant glioma	0.000109	0.000995	CbGeAlD
Sunitinib—LRRK2—central nervous system—malignant glioma	0.000108	0.000991	CbGeAlD
Sunitinib—JAK2—spinal cord—malignant glioma	0.000108	0.00099	CbGeAlD
Sunitinib—HIPK2—brain—malignant glioma	0.000108	0.00099	CbGeAlD
Sunitinib—HIPK3—brain—malignant glioma	0.000108	0.00099	CbGeAlD
Sunitinib—TYRO3—brain—malignant glioma	0.000108	0.00099	CbGeAlD
Sunitinib—ALK—brain—malignant glioma	0.000108	0.00099	CbGeAlD
Sunitinib—Rash—Temozolomide—malignant glioma	0.000108	0.00185	CcSEcCtD
Sunitinib—YES1—medulla oblongata—malignant glioma	0.000108	0.000989	CbGeAlD
Sunitinib—Dermatitis—Temozolomide—malignant glioma	0.000108	0.00185	CcSEcCtD
Sunitinib—KIT—telencephalon—malignant glioma	0.000108	0.000987	CbGeAlD
Sunitinib—Headache—Temozolomide—malignant glioma	0.000107	0.00184	CcSEcCtD
Sunitinib—TNK1—brain—malignant glioma	0.000107	0.00098	CbGeAlD
Sunitinib—RIOK2—brain—malignant glioma	0.000107	0.00098	CbGeAlD
Sunitinib—MAP3K3—midbrain—malignant glioma	0.000107	0.000978	CbGeAlD
Sunitinib—MAP4K5—midbrain—malignant glioma	0.000107	0.000978	CbGeAlD
Sunitinib—CAMK2G—cerebellum—malignant glioma	0.000107	0.000977	CbGeAlD
Sunitinib—BMP2K—cerebellum—malignant glioma	0.000107	0.000977	CbGeAlD
Sunitinib—FYN—spinal cord—malignant glioma	0.000107	0.000977	CbGeAlD
Sunitinib—PRKAA1—central nervous system—malignant glioma	0.000107	0.000976	CbGeAlD
Sunitinib—TAOK3—medulla oblongata—malignant glioma	0.000107	0.000976	CbGeAlD
Sunitinib—MAP4K1—brain—malignant glioma	0.000106	0.00097	CbGeAlD
Sunitinib—MAP3K19—brain—malignant glioma	0.000106	0.00097	CbGeAlD
Sunitinib—LRRK2—cerebellum—malignant glioma	0.000106	0.000968	CbGeAlD
Sunitinib—PTK2B—central nervous system—malignant glioma	0.000106	0.000966	CbGeAlD
Sunitinib—Nausea—Carmustine—malignant glioma	0.000105	0.0018	CcSEcCtD
Sunitinib—PDGFRB—telencephalon—malignant glioma	0.000105	0.000964	CbGeAlD
Sunitinib—MAP3K3—spinal cord—malignant glioma	0.000104	0.000954	CbGeAlD
Sunitinib—MAP4K5—spinal cord—malignant glioma	0.000104	0.000954	CbGeAlD
Sunitinib—PRKAA1—cerebellum—malignant glioma	0.000104	0.000954	CbGeAlD
Sunitinib—DAPK3—brain—malignant glioma	0.000104	0.000951	CbGeAlD
Sunitinib—CSNK1E—central nervous system—malignant glioma	0.000104	0.00095	CbGeAlD
Sunitinib—FLT1—midbrain—malignant glioma	0.000104	0.000946	CbGeAlD
Sunitinib—PTK2B—cerebellum—malignant glioma	0.000103	0.000944	CbGeAlD
Sunitinib—CLK2—brain—malignant glioma	0.000103	0.000942	CbGeAlD
Sunitinib—MAP4K2—brain—malignant glioma	0.000103	0.000938	CbGeAlD
Sunitinib—IRAK4—central nervous system—malignant glioma	0.000102	0.000935	CbGeAlD
Sunitinib—EPHB6—midbrain—malignant glioma	0.000102	0.000935	CbGeAlD
Sunitinib—Nausea—Temozolomide—malignant glioma	0.000102	0.00174	CcSEcCtD
Sunitinib—CSNK1E—cerebellum—malignant glioma	0.000102	0.000928	CbGeAlD
Sunitinib—FGFR1—cerebellum—malignant glioma	0.000102	0.000928	CbGeAlD
Sunitinib—STK3—brain—malignant glioma	0.000101	0.000925	CbGeAlD
Sunitinib—FLT1—spinal cord—malignant glioma	0.000101	0.000923	CbGeAlD
Sunitinib—MAP2K2—central nervous system—malignant glioma	0.0001	0.000914	CbGeAlD
Sunitinib—ULK3—central nervous system—malignant glioma	0.0001	0.000914	CbGeAlD
Sunitinib—IRAK4—cerebellum—malignant glioma	0.0001	0.000914	CbGeAlD
Sunitinib—ROCK1—brain—malignant glioma	9.99e-05	0.000913	CbGeAlD
Sunitinib—EPHB6—spinal cord—malignant glioma	9.98e-05	0.000912	CbGeAlD
Sunitinib—MAP3K2—central nervous system—malignant glioma	9.93e-05	0.000908	CbGeAlD
Sunitinib—YES1—midbrain—malignant glioma	9.89e-05	0.000904	CbGeAlD
Sunitinib—MAP2K2—cerebellum—malignant glioma	9.78e-05	0.000894	CbGeAlD
Sunitinib—ULK3—cerebellum—malignant glioma	9.78e-05	0.000894	CbGeAlD
Sunitinib—TAOK3—midbrain—malignant glioma	9.76e-05	0.000892	CbGeAlD
Sunitinib—DYRK1A—brain—malignant glioma	9.75e-05	0.00089	CbGeAlD
Sunitinib—TBK1—central nervous system—malignant glioma	9.73e-05	0.000889	CbGeAlD
Sunitinib—MAP3K2—cerebellum—malignant glioma	9.71e-05	0.000887	CbGeAlD
Sunitinib—TYK2—central nervous system—malignant glioma	9.66e-05	0.000883	CbGeAlD
Sunitinib—YES1—spinal cord—malignant glioma	9.65e-05	0.000882	CbGeAlD
Sunitinib—MAP3K7—cerebellum—malignant glioma	9.62e-05	0.000879	CbGeAlD
Sunitinib—KDR—medulla oblongata—malignant glioma	9.57e-05	0.000875	CbGeAlD
Sunitinib—MAP2K5—medulla oblongata—malignant glioma	9.57e-05	0.000875	CbGeAlD
Sunitinib—TAOK3—spinal cord—malignant glioma	9.52e-05	0.00087	CbGeAlD
Sunitinib—MERTK—brain—malignant glioma	9.52e-05	0.00087	CbGeAlD
Sunitinib—TBK1—cerebellum—malignant glioma	9.51e-05	0.000869	CbGeAlD
Sunitinib—PDGFRA—spinal cord—malignant glioma	9.46e-05	0.000865	CbGeAlD
Sunitinib—TYK2—cerebellum—malignant glioma	9.45e-05	0.000863	CbGeAlD
Sunitinib—RPS6KB1—central nervous system—malignant glioma	9.36e-05	0.000855	CbGeAlD
Sunitinib—CSF1R—medulla oblongata—malignant glioma	9.34e-05	0.000854	CbGeAlD
Sunitinib—MAP4K4—brain—malignant glioma	9.34e-05	0.000854	CbGeAlD
Sunitinib—IRAK1—cerebellum—malignant glioma	9.32e-05	0.000852	CbGeAlD
Sunitinib—FGR—central nervous system—malignant glioma	9.3e-05	0.00085	CbGeAlD
Sunitinib—RET—central nervous system—malignant glioma	9.3e-05	0.00085	CbGeAlD
Sunitinib—NUAK2—brain—malignant glioma	9.28e-05	0.000848	CbGeAlD
Sunitinib—AXL—central nervous system—malignant glioma	9.27e-05	0.000847	CbGeAlD
Sunitinib—MAP3K12—brain—malignant glioma	9.21e-05	0.000842	CbGeAlD
Sunitinib—RPS6KB1—cerebellum—malignant glioma	9.15e-05	0.000836	CbGeAlD
Sunitinib—RET—cerebellum—malignant glioma	9.09e-05	0.000831	CbGeAlD
Sunitinib—RPS6KA3—brain—malignant glioma	9.08e-05	0.00083	CbGeAlD
Sunitinib—AXL—cerebellum—malignant glioma	9.06e-05	0.000827	CbGeAlD
Sunitinib—MAP2K1—brain—malignant glioma	9.02e-05	0.000825	CbGeAlD
Sunitinib—CSNK1A1—brain—malignant glioma	8.91e-05	0.000814	CbGeAlD
Sunitinib—CLK1—brain—malignant glioma	8.85e-05	0.000809	CbGeAlD
Sunitinib—FGFR2—central nervous system—malignant glioma	8.84e-05	0.000808	CbGeAlD
Sunitinib—JAK2—central nervous system—malignant glioma	8.79e-05	0.000803	CbGeAlD
Sunitinib—MAP2K5—midbrain—malignant glioma	8.75e-05	0.0008	CbGeAlD
Sunitinib—KDR—midbrain—malignant glioma	8.75e-05	0.0008	CbGeAlD
Sunitinib—SLK—cerebellum—malignant glioma	8.72e-05	0.000797	CbGeAlD
Sunitinib—BMP2K—brain—malignant glioma	8.69e-05	0.000794	CbGeAlD
Sunitinib—CAMK2G—brain—malignant glioma	8.69e-05	0.000794	CbGeAlD
Sunitinib—FYN—central nervous system—malignant glioma	8.67e-05	0.000792	CbGeAlD
Sunitinib—FGFR2—cerebellum—malignant glioma	8.64e-05	0.000789	CbGeAlD
Sunitinib—LRRK2—brain—malignant glioma	8.61e-05	0.000787	CbGeAlD
Sunitinib—JAK2—cerebellum—malignant glioma	8.59e-05	0.000785	CbGeAlD
Sunitinib—CSF1R—midbrain—malignant glioma	8.54e-05	0.00078	CbGeAlD
Sunitinib—KDR—spinal cord—malignant glioma	8.54e-05	0.00078	CbGeAlD
Sunitinib—MAP2K5—spinal cord—malignant glioma	8.54e-05	0.00078	CbGeAlD
Sunitinib—KIT—medulla oblongata—malignant glioma	8.48e-05	0.000775	CbGeAlD
Sunitinib—PRKAA1—brain—malignant glioma	8.48e-05	0.000775	CbGeAlD
Sunitinib—FYN—cerebellum—malignant glioma	8.48e-05	0.000774	CbGeAlD
Sunitinib—MAP4K5—central nervous system—malignant glioma	8.47e-05	0.000774	CbGeAlD
Sunitinib—MAP3K3—central nervous system—malignant glioma	8.47e-05	0.000774	CbGeAlD
Sunitinib—PTK2B—brain—malignant glioma	8.39e-05	0.000767	CbGeAlD
Sunitinib—FLT4—brain—malignant glioma	8.37e-05	0.000764	CbGeAlD
Sunitinib—CSF1R—spinal cord—malignant glioma	8.33e-05	0.000761	CbGeAlD
Sunitinib—PDGFRB—medulla oblongata—malignant glioma	8.29e-05	0.000757	CbGeAlD
Sunitinib—MAP4K5—cerebellum—malignant glioma	8.28e-05	0.000757	CbGeAlD
Sunitinib—MAP3K3—cerebellum—malignant glioma	8.28e-05	0.000757	CbGeAlD
Sunitinib—CSNK1E—brain—malignant glioma	8.25e-05	0.000754	CbGeAlD
Sunitinib—FGFR1—brain—malignant glioma	8.25e-05	0.000754	CbGeAlD
Sunitinib—FLT1—central nervous system—malignant glioma	8.19e-05	0.000749	CbGeAlD
Sunitinib—IRAK4—brain—malignant glioma	8.12e-05	0.000742	CbGeAlD
Sunitinib—EPHB6—central nervous system—malignant glioma	8.1e-05	0.00074	CbGeAlD
Sunitinib—FLT1—cerebellum—malignant glioma	8.01e-05	0.000732	CbGeAlD
Sunitinib—ULK3—brain—malignant glioma	7.94e-05	0.000726	CbGeAlD
Sunitinib—MAP2K2—brain—malignant glioma	7.94e-05	0.000726	CbGeAlD
Sunitinib—EPHB6—cerebellum—malignant glioma	7.92e-05	0.000723	CbGeAlD
Sunitinib—MAP3K2—brain—malignant glioma	7.89e-05	0.000721	CbGeAlD
Sunitinib—YES1—central nervous system—malignant glioma	7.83e-05	0.000715	CbGeAlD
Sunitinib—MAP3K7—brain—malignant glioma	7.81e-05	0.000714	CbGeAlD
Sunitinib—STK10—central nervous system—malignant glioma	7.76e-05	0.000709	CbGeAlD
Sunitinib—KIT—midbrain—malignant glioma	7.75e-05	0.000709	CbGeAlD
Sunitinib—TAOK3—central nervous system—malignant glioma	7.73e-05	0.000706	CbGeAlD
Sunitinib—TBK1—brain—malignant glioma	7.72e-05	0.000706	CbGeAlD
Sunitinib—PDGFRA—central nervous system—malignant glioma	7.68e-05	0.000702	CbGeAlD
Sunitinib—TYK2—brain—malignant glioma	7.67e-05	0.000701	CbGeAlD
Sunitinib—YES1—cerebellum—malignant glioma	7.65e-05	0.000699	CbGeAlD
Sunitinib—STK10—cerebellum—malignant glioma	7.58e-05	0.000693	CbGeAlD
Sunitinib—PDGFRB—midbrain—malignant glioma	7.57e-05	0.000692	CbGeAlD
Sunitinib—IRAK1—brain—malignant glioma	7.57e-05	0.000692	CbGeAlD
Sunitinib—KIT—spinal cord—malignant glioma	7.57e-05	0.000691	CbGeAlD
Sunitinib—TAOK3—cerebellum—malignant glioma	7.55e-05	0.00069	CbGeAlD
Sunitinib—PDGFRA—cerebellum—malignant glioma	7.5e-05	0.000686	CbGeAlD
Sunitinib—RPS6KB1—brain—malignant glioma	7.43e-05	0.000679	CbGeAlD
Sunitinib—PDGFRB—spinal cord—malignant glioma	7.39e-05	0.000675	CbGeAlD
Sunitinib—FGR—brain—malignant glioma	7.39e-05	0.000675	CbGeAlD
Sunitinib—RET—brain—malignant glioma	7.39e-05	0.000675	CbGeAlD
Sunitinib—AXL—brain—malignant glioma	7.36e-05	0.000672	CbGeAlD
Sunitinib—SLK—brain—malignant glioma	7.08e-05	0.000647	CbGeAlD
Sunitinib—FGFR2—brain—malignant glioma	7.02e-05	0.000641	CbGeAlD
Sunitinib—JAK2—brain—malignant glioma	6.98e-05	0.000638	CbGeAlD
Sunitinib—KDR—central nervous system—malignant glioma	6.93e-05	0.000633	CbGeAlD
Sunitinib—MAP2K5—central nervous system—malignant glioma	6.93e-05	0.000633	CbGeAlD
Sunitinib—FYN—brain—malignant glioma	6.88e-05	0.000629	CbGeAlD
Sunitinib—KDR—cerebellum—malignant glioma	6.77e-05	0.000619	CbGeAlD
Sunitinib—MAP2K5—cerebellum—malignant glioma	6.77e-05	0.000619	CbGeAlD
Sunitinib—CSF1R—central nervous system—malignant glioma	6.76e-05	0.000618	CbGeAlD
Sunitinib—MAP4K5—brain—malignant glioma	6.73e-05	0.000615	CbGeAlD
Sunitinib—MAP3K3—brain—malignant glioma	6.73e-05	0.000615	CbGeAlD
Sunitinib—KCNH2—telencephalon—malignant glioma	6.66e-05	0.000609	CbGeAlD
Sunitinib—CSF1R—cerebellum—malignant glioma	6.61e-05	0.000604	CbGeAlD
Sunitinib—FLT1—brain—malignant glioma	6.5e-05	0.000594	CbGeAlD
Sunitinib—EPHB6—brain—malignant glioma	6.43e-05	0.000588	CbGeAlD
Sunitinib—YES1—brain—malignant glioma	6.21e-05	0.000568	CbGeAlD
Sunitinib—STK10—brain—malignant glioma	6.16e-05	0.000563	CbGeAlD
Sunitinib—KIT—central nervous system—malignant glioma	6.14e-05	0.000561	CbGeAlD
Sunitinib—TAOK3—brain—malignant glioma	6.13e-05	0.00056	CbGeAlD
Sunitinib—PDGFRA—brain—malignant glioma	6.1e-05	0.000557	CbGeAlD
Sunitinib—ABCB1—blood vessel—malignant glioma	6.03e-05	0.000551	CbGeAlD
Sunitinib—KIT—cerebellum—malignant glioma	6e-05	0.000548	CbGeAlD
Sunitinib—PDGFRB—central nervous system—malignant glioma	5.99e-05	0.000548	CbGeAlD
Sunitinib—ABCG2—telencephalon—malignant glioma	5.93e-05	0.000542	CbGeAlD
Sunitinib—PDGFRB—cerebellum—malignant glioma	5.86e-05	0.000535	CbGeAlD
Sunitinib—MAP2K5—brain—malignant glioma	5.5e-05	0.000502	CbGeAlD
Sunitinib—KDR—brain—malignant glioma	5.5e-05	0.000502	CbGeAlD
Sunitinib—CSF1R—brain—malignant glioma	5.37e-05	0.00049	CbGeAlD
Sunitinib—KCNH2—medulla oblongata—malignant glioma	5.24e-05	0.000478	CbGeAlD
Sunitinib—KIT—brain—malignant glioma	4.87e-05	0.000445	CbGeAlD
Sunitinib—KCNH2—midbrain—malignant glioma	4.79e-05	0.000437	CbGeAlD
Sunitinib—ABCC4—central nervous system—malignant glioma	4.77e-05	0.000436	CbGeAlD
Sunitinib—PDGFRB—brain—malignant glioma	4.76e-05	0.000435	CbGeAlD
Sunitinib—KCNH2—spinal cord—malignant glioma	4.67e-05	0.000427	CbGeAlD
Sunitinib—ABCG2—medulla oblongata—malignant glioma	4.66e-05	0.000426	CbGeAlD
Sunitinib—ABCG2—midbrain—malignant glioma	4.26e-05	0.000389	CbGeAlD
Sunitinib—ABCG2—spinal cord—malignant glioma	4.15e-05	0.00038	CbGeAlD
Sunitinib—ABCC4—brain—malignant glioma	3.79e-05	0.000346	CbGeAlD
Sunitinib—KCNH2—central nervous system—malignant glioma	3.79e-05	0.000346	CbGeAlD
Sunitinib—KCNH2—cerebellum—malignant glioma	3.7e-05	0.000338	CbGeAlD
Sunitinib—ABCB1—embryo—malignant glioma	3.59e-05	0.000328	CbGeAlD
Sunitinib—ABCG2—cerebellum—malignant glioma	3.29e-05	0.000301	CbGeAlD
Sunitinib—ABCB1—retina—malignant glioma	3.18e-05	0.00029	CbGeAlD
Sunitinib—KCNH2—brain—malignant glioma	3.01e-05	0.000275	CbGeAlD
Sunitinib—ABCB1—telencephalon—malignant glioma	2.92e-05	0.000267	CbGeAlD
Sunitinib—ABCG2—brain—malignant glioma	2.67e-05	0.000244	CbGeAlD
Sunitinib—CYP3A4—central nervous system—malignant glioma	2.35e-05	0.000214	CbGeAlD
Sunitinib—ABCB1—medulla oblongata—malignant glioma	2.3e-05	0.00021	CbGeAlD
Sunitinib—ABCB1—midbrain—malignant glioma	2.1e-05	0.000192	CbGeAlD
Sunitinib—ABCB1—spinal cord—malignant glioma	2.05e-05	0.000187	CbGeAlD
Sunitinib—ABCB1—central nervous system—malignant glioma	1.66e-05	0.000152	CbGeAlD
Sunitinib—ABCB1—cerebellum—malignant glioma	1.62e-05	0.000148	CbGeAlD
Sunitinib—ABCB1—brain—malignant glioma	1.32e-05	0.000121	CbGeAlD
Sunitinib—NTRK1—Signaling Pathways—PIK3CA—malignant glioma	4.6e-07	2.53e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—VEGFA—malignant glioma	4.58e-07	2.52e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—ERBB2—malignant glioma	4.58e-07	2.52e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—KRAS—malignant glioma	4.58e-07	2.51e-06	CbGpPWpGaD
Sunitinib—FGFR1—Disease—PIK3CA—malignant glioma	4.57e-07	2.51e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—MMP9—malignant glioma	4.56e-07	2.5e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—EGFR—malignant glioma	4.56e-07	2.5e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—PIK3CA—malignant glioma	4.55e-07	2.5e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—PIK3CA—malignant glioma	4.55e-07	2.5e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—MMP9—malignant glioma	4.55e-07	2.5e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—PIK3CB—malignant glioma	4.54e-07	2.5e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—STAT3—malignant glioma	4.54e-07	2.49e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—PTEN—malignant glioma	4.53e-07	2.49e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—EGFR—malignant glioma	4.53e-07	2.49e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—GSTP1—malignant glioma	4.53e-07	2.49e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—CXCL8—malignant glioma	4.53e-07	2.49e-06	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—AKT1—malignant glioma	4.52e-07	2.48e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—PTEN—malignant glioma	4.52e-07	2.48e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—PIK3CB—malignant glioma	4.52e-07	2.48e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—CAV1—malignant glioma	4.5e-07	2.47e-06	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—TP53—malignant glioma	4.48e-07	2.46e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—KRAS—malignant glioma	4.47e-07	2.45e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—PIK3CA—malignant glioma	4.46e-07	2.45e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—PIK3CA—malignant glioma	4.46e-07	2.45e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—PIK3CA—malignant glioma	4.46e-07	2.45e-06	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—TP53—malignant glioma	4.45e-07	2.44e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—VEGFA—malignant glioma	4.45e-07	2.44e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—MYC—malignant glioma	4.44e-07	2.44e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—PIK3CA—malignant glioma	4.44e-07	2.44e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—CASP3—malignant glioma	4.44e-07	2.44e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—MDM2—malignant glioma	4.44e-07	2.44e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—IL2—malignant glioma	4.44e-07	2.44e-06	CbGpPWpGaD
Sunitinib—JAK2—Immune System—KRAS—malignant glioma	4.43e-07	2.43e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—MYC—malignant glioma	4.43e-07	2.43e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—RAF1—malignant glioma	4.42e-07	2.43e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—CAT—malignant glioma	4.41e-07	2.42e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—STAT3—malignant glioma	4.4e-07	2.42e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—VEGFA—malignant glioma	4.39e-07	2.41e-06	CbGpPWpGaD
Sunitinib—TYK2—Immune System—AKT1—malignant glioma	4.39e-07	2.41e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—PIK3CB—malignant glioma	4.38e-07	2.41e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—ERBB2—malignant glioma	4.38e-07	2.4e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—CXCL8—malignant glioma	4.37e-07	2.4e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—STAT3—malignant glioma	4.35e-07	2.39e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—EGFR—malignant glioma	4.35e-07	2.39e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—PIK3CA—malignant glioma	4.35e-07	2.39e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—PIK3CB—malignant glioma	4.34e-07	2.39e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—CXCL8—malignant glioma	4.34e-07	2.39e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—PTGS2—malignant glioma	4.34e-07	2.39e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—CASP3—malignant glioma	4.34e-07	2.38e-06	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—AKT1—malignant glioma	4.34e-07	2.38e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—EGFR—malignant glioma	4.33e-07	2.38e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—IL2—malignant glioma	4.33e-07	2.38e-06	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—AKT1—malignant glioma	4.32e-07	2.37e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—PIK3CB—malignant glioma	4.32e-07	2.37e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—VEGFA—malignant glioma	4.31e-07	2.37e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—VEGFA—malignant glioma	4.31e-07	2.37e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—TP53—malignant glioma	4.31e-07	2.37e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—TP53—malignant glioma	4.31e-07	2.37e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—KRAS—malignant glioma	4.31e-07	2.37e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—PTGS2—malignant glioma	4.3e-07	2.36e-06	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—AKT1—malignant glioma	4.28e-07	2.35e-06	CbGpPWpGaD
Sunitinib—FYN—Immune System—PIK3CA—malignant glioma	4.28e-07	2.35e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—KRAS—malignant glioma	4.28e-07	2.35e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—STAT3—malignant glioma	4.27e-07	2.35e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—STAT3—malignant glioma	4.27e-07	2.35e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—PIK3CA—malignant glioma	4.26e-07	2.34e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—AKT1—malignant glioma	4.26e-07	2.34e-06	CbGpPWpGaD
Sunitinib—KIT—Immune System—AKT1—malignant glioma	4.26e-07	2.34e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—MYC—malignant glioma	4.22e-07	2.32e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—PIK3CA—malignant glioma	4.2e-07	2.31e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—TP53—malignant glioma	4.2e-07	2.31e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—MMP9—malignant glioma	4.2e-07	2.31e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—CASP3—malignant glioma	4.18e-07	2.3e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—PTEN—malignant glioma	4.17e-07	2.29e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—IL2—malignant glioma	4.17e-07	2.29e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—NCOR1—malignant glioma	4.16e-07	2.29e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—CASP3—malignant glioma	4.16e-07	2.28e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—CXCL8—malignant glioma	4.15e-07	2.28e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—IL2—malignant glioma	4.15e-07	2.28e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—EGFR—malignant glioma	4.12e-07	2.27e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—KRAS—malignant glioma	4.11e-07	2.26e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—PIK3CA—malignant glioma	4.1e-07	2.25e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—PIK3CG—malignant glioma	4.1e-07	2.25e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—MMP9—malignant glioma	4.1e-07	2.25e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—VEGFA—malignant glioma	4.09e-07	2.25e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—MYC—malignant glioma	4.09e-07	2.25e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—KRAS—malignant glioma	4.09e-07	2.25e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—VEGFA—malignant glioma	4.08e-07	2.24e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—PTEN—malignant glioma	4.07e-07	2.24e-06	CbGpPWpGaD
Sunitinib—JAK2—Immune System—PIK3CA—malignant glioma	4.07e-07	2.24e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by GPCR—AKT1—malignant glioma	4.07e-07	2.24e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—STAT3—malignant glioma	4.05e-07	2.23e-06	CbGpPWpGaD
Sunitinib—TYK2—Disease—AKT1—malignant glioma	4.05e-07	2.23e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—STAT3—malignant glioma	4.04e-07	2.22e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—MYC—malignant glioma	4.04e-07	2.22e-06	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—AKT1—malignant glioma	4.04e-07	2.22e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—AKT1—malignant glioma	4.03e-07	2.21e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GSTT1—malignant glioma	4.03e-07	2.21e-06	CbGpPWpGaD
Sunitinib—JAK2—GPCR downstream signaling—AKT1—malignant glioma	4.01e-07	2.2e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—EGFR—malignant glioma	4e-07	2.2e-06	CbGpPWpGaD
Sunitinib—FGFR2—Disease—AKT1—malignant glioma	4e-07	2.2e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—CASP3—malignant glioma	3.97e-07	2.18e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—MYC—malignant glioma	3.97e-07	2.18e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—MYC—malignant glioma	3.97e-07	2.18e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—IL2—malignant glioma	3.97e-07	2.18e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—PIK3CA—malignant glioma	3.96e-07	2.17e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—PPARG—malignant glioma	3.96e-07	2.17e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—EGFR—malignant glioma	3.95e-07	2.17e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—MMP9—malignant glioma	3.95e-07	2.17e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—PIK3CA—malignant glioma	3.93e-07	2.16e-06	CbGpPWpGaD
Sunitinib—KIT—Disease—AKT1—malignant glioma	3.93e-07	2.16e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—MMP9—malignant glioma	3.93e-07	2.16e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—PTEN—malignant glioma	3.93e-07	2.16e-06	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—AKT1—malignant glioma	3.93e-07	2.16e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—PTEN—malignant glioma	3.91e-07	2.15e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—KRAS—malignant glioma	3.9e-07	2.14e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—EGFR—malignant glioma	3.88e-07	2.13e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—EGFR—malignant glioma	3.88e-07	2.13e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—AKT1—malignant glioma	3.81e-07	2.09e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—PTEN—malignant glioma	3.79e-07	2.08e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—KRAS—malignant glioma	3.78e-07	2.08e-06	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—AKT1—malignant glioma	3.78e-07	2.08e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PTGS1—malignant glioma	3.77e-07	2.07e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—PIK3CA—malignant glioma	3.77e-07	2.07e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—VEGFA—malignant glioma	3.77e-07	2.07e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—MYC—malignant glioma	3.77e-07	2.07e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—PIK3CA—malignant glioma	3.76e-07	2.07e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—MYC—malignant glioma	3.76e-07	2.06e-06	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—AKT1—malignant glioma	3.76e-07	2.06e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—MMP9—malignant glioma	3.75e-07	2.06e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—PTEN—malignant glioma	3.75e-07	2.06e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—KRAS—malignant glioma	3.73e-07	2.05e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—STAT3—malignant glioma	3.73e-07	2.05e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—PTEN—malignant glioma	3.73e-07	2.05e-06	CbGpPWpGaD
Sunitinib—FGFR1—Disease—AKT1—malignant glioma	3.73e-07	2.05e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—AKT1—malignant glioma	3.72e-07	2.04e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—AKT1—malignant glioma	3.72e-07	2.04e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—EGFR—malignant glioma	3.68e-07	2.02e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—VEGFA—malignant glioma	3.68e-07	2.02e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—EGFR—malignant glioma	3.68e-07	2.02e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—KRAS—malignant glioma	3.67e-07	2.01e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—KRAS—malignant glioma	3.67e-07	2.01e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—TP53—malignant glioma	3.65e-07	2.01e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—AKT1—malignant glioma	3.64e-07	2e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—STAT3—malignant glioma	3.64e-07	2e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—AKT1—malignant glioma	3.64e-07	2e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—AKT1—malignant glioma	3.64e-07	2e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—AKT1—malignant glioma	3.63e-07	1.99e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—PIK3CD—malignant glioma	3.6e-07	1.98e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—PIK3CA—malignant glioma	3.58e-07	1.97e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—AKT1—malignant glioma	3.55e-07	1.95e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—VEGFA—malignant glioma	3.55e-07	1.95e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—VEGFA—malignant glioma	3.53e-07	1.94e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—STAT3—malignant glioma	3.51e-07	1.93e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—BCHE—malignant glioma	3.51e-07	1.93e-06	CbGpPWpGaD
Sunitinib—FYN—Immune System—AKT1—malignant glioma	3.5e-07	1.92e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—STAT3—malignant glioma	3.49e-07	1.92e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—AKT1—malignant glioma	3.48e-07	1.91e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—KRAS—malignant glioma	3.48e-07	1.91e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—PIK3CA—malignant glioma	3.47e-07	1.91e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—KRAS—malignant glioma	3.47e-07	1.91e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—MYC—malignant glioma	3.47e-07	1.91e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—SLC5A5—malignant glioma	3.47e-07	1.9e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—TP53—malignant glioma	3.46e-07	1.9e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—AKT1—malignant glioma	3.44e-07	1.89e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—PIK3CA—malignant glioma	3.43e-07	1.88e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—CAV1—malignant glioma	3.39e-07	1.86e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—EGFR—malignant glioma	3.39e-07	1.86e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—MYC—malignant glioma	3.38e-07	1.86e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—VEGFA—malignant glioma	3.37e-07	1.85e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—PIK3CA—malignant glioma	3.37e-07	1.85e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—PIK3CA—malignant glioma	3.37e-07	1.85e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—TP53—malignant glioma	3.36e-07	1.85e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—AKT1—malignant glioma	3.35e-07	1.84e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—STAT3—malignant glioma	3.34e-07	1.83e-06	CbGpPWpGaD
Sunitinib—JAK2—Immune System—AKT1—malignant glioma	3.33e-07	1.83e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—TP53—malignant glioma	3.32e-07	1.82e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—EGFR—malignant glioma	3.31e-07	1.82e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—MYC—malignant glioma	3.26e-07	1.79e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—TP53—malignant glioma	3.26e-07	1.79e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—TP53—malignant glioma	3.26e-07	1.79e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—MYC—malignant glioma	3.25e-07	1.78e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—AKT1—malignant glioma	3.23e-07	1.78e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—AKT1—malignant glioma	3.21e-07	1.77e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—KRAS—malignant glioma	3.21e-07	1.76e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—PIK3CA—malignant glioma	3.2e-07	1.76e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—EGFR—malignant glioma	3.19e-07	1.75e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—PIK3CA—malignant glioma	3.19e-07	1.75e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—EGFR—malignant glioma	3.17e-07	1.74e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—PIK3CB—malignant glioma	3.14e-07	1.72e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—KRAS—malignant glioma	3.13e-07	1.72e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—PTGS2—malignant glioma	3.11e-07	1.71e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—MYC—malignant glioma	3.1e-07	1.7e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—TP53—malignant glioma	3.09e-07	1.7e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PIK3CG—malignant glioma	3.09e-07	1.7e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—TP53—malignant glioma	3.09e-07	1.7e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—AKT1—malignant glioma	3.08e-07	1.69e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—AKT1—malignant glioma	3.07e-07	1.69e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—EGFR—malignant glioma	3.03e-07	1.67e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—KRAS—malignant glioma	3.01e-07	1.66e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—KRAS—malignant glioma	3e-07	1.65e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PPARG—malignant glioma	2.98e-07	1.64e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—PIK3CA—malignant glioma	2.94e-07	1.62e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—AKT1—malignant glioma	2.92e-07	1.61e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—PIK3CA—malignant glioma	2.87e-07	1.58e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—KRAS—malignant glioma	2.87e-07	1.57e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—TP53—malignant glioma	2.85e-07	1.56e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—AKT1—malignant glioma	2.84e-07	1.56e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—AKT1—malignant glioma	2.8e-07	1.54e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GSTP1—malignant glioma	2.79e-07	1.53e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—TP53—malignant glioma	2.78e-07	1.53e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—PIK3CA—malignant glioma	2.77e-07	1.52e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—PIK3CA—malignant glioma	2.75e-07	1.51e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—AKT1—malignant glioma	2.75e-07	1.51e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—AKT1—malignant glioma	2.75e-07	1.51e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PIK3CD—malignant glioma	2.72e-07	1.49e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CAT—malignant glioma	2.72e-07	1.49e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—PTEN—malignant glioma	2.71e-07	1.49e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—TP53—malignant glioma	2.68e-07	1.47e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—PIK3CA—malignant glioma	2.67e-07	1.47e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—TP53—malignant glioma	2.67e-07	1.46e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—PIK3CA—malignant glioma	2.65e-07	1.45e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—PIK3CA—malignant glioma	2.63e-07	1.45e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—AKT1—malignant glioma	2.61e-07	1.44e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—AKT1—malignant glioma	2.61e-07	1.43e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—NCOR1—malignant glioma	2.57e-07	1.41e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—TP53—malignant glioma	2.55e-07	1.4e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—AKT1—malignant glioma	2.41e-07	1.32e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PIK3CB—malignant glioma	2.37e-07	1.3e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PTGS2—malignant glioma	2.35e-07	1.29e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—AKT1—malignant glioma	2.35e-07	1.29e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—AKT1—malignant glioma	2.26e-07	1.24e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—AKT1—malignant glioma	2.25e-07	1.24e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—AKT1—malignant glioma	2.18e-07	1.2e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—AKT1—malignant glioma	2.16e-07	1.19e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—AKT1—malignant glioma	2.15e-07	1.18e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CAV1—malignant glioma	2.09e-07	1.15e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PTEN—malignant glioma	2.05e-07	1.12e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—PIK3CA—malignant glioma	1.91e-07	1.05e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PIK3CG—malignant glioma	1.91e-07	1.05e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PPARG—malignant glioma	1.84e-07	1.01e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PIK3CD—malignant glioma	1.67e-07	9.2e-07	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—AKT1—malignant glioma	1.56e-07	8.59e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.46e-07	8.02e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PTGS2—malignant glioma	1.45e-07	7.95e-07	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PIK3CA—malignant glioma	1.44e-07	7.94e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PTEN—malignant glioma	1.26e-07	6.93e-07	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—AKT1—malignant glioma	1.18e-07	6.48e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PIK3CA—malignant glioma	8.9e-08	4.89e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—AKT1—malignant glioma	7.27e-08	3.99e-07	CbGpPWpGaD
